Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 6, 2012, Pages 498-507

  Soshitova, Natalia P ^a   Karamzin, Sergey S ^a   Balandina, Anna N ^b,c   Fadeeva, Olga A ^a   Kretchetova, Anna V ^b   Galstian, Gennadiy M ^b   Panteleev, Mikhail A ^a,b,c,d   Ataullakhanov, Fazoil I ^a,b,c,d,e  

^a HemaCore LLC   (Russian Federation)

^b NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^c CENTER FOR THEORETICAL PROBLEMS OF PHYSICOCHEMICAL PHARMACOLOGY   (Russian Federation)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

^e Federal Research and Clinical Center of Pediatric Hematology   (Russian Federation)

Author keywords

disseminated intravascular coagulation; hypercoagulation; sepsis; spatial clot growth; thrombodynamics; thrombosis

Indexed keywords

D DIMER;

ADULT; ARTICLE; ASSAY; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FIBRIN CLOT; HEMATOLOGIC MALIGNANCY; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPOCOAGULABILITY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEPSIS; SEPTIC SHOCK; SPATIAL CLOT GROWTH ASSAY; THROMBOCYTE FREE PLASMA; THROMBOELASTOGRAPHY; VEIN THROMBOSIS;

ADULT; BLOOD COAGULATION TESTS; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEPSIS; SURVIVAL ANALYSIS; THROMBOSIS;

EID: 84865500506     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328352e90e     Document Type: Article

References (36)

1. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, Kurosawa S. Inflammation, sepsis, and coagulation. Haematologica 1999; 84:254-259. (Pubitemid 29476931)
2. Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie 2010; 30:10-16.
3. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care 2006; 10:222.
4. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis 2010; 2:e2010024.
5. Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 2006; 17:445-451. (Pubitemid 44231689)
6. Bastarache JA, Ware LB, Bernard GR. The role of the coagulation cascade in the continuum of sepsis and acute lung injury and acute respiratory distress syndrome. Semin Respir Crit Care Med 2006; 27:365-376. (Pubitemid 44272605)
7. Knoebl P, Dempfle CE. Blood coagulation and inflammation in critical illness. Bremen: UNI-MED, 2008.
8. Stief TW, Ijagha O, Weiste B, Herzum I, Renz H, Max M. Analysis of hemostasis alterations in sepsis. Blood Coagul Fibrinolysis 2007; 18:179-186. (Pubitemid 46232840)
9. Baglin T. Using the laboratory to predict recurrent venous thrombosis. Int J Lab Hematol 2011; 33:333-342.
10. Dempfle CE. Coagulopathy of sepsis. Thromb Haemost 2004; 91:213-224.
11. Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006; 135:220-227. (Pubitemid 44401620)
12. Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009; 20:419-426.
13. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009; 13:R42.
14. Seo JW, Kim HK, Kim JE, Park S, Cho HI. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation. Thromb Res 2009; 123:565-572.
15. Ovanesov MV, Krasotkina JV, Ul'yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, et al. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta 2002; 1572:45-57. (Pubitemid 35223055)
16. Negrier C, Dargaud Y, Bordet JC. Basic aspects of bypassing agents. Haemophilia 2006; 12 (Suppl 6):48-52.
17. Ovanesov MV, Ananyeva NM, Panteleev MA, Ataullakhanov FI, Saenko EL. Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate. J Thromb Haemost 2005; 3:321-331. (Pubitemid 41623621)
18. Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, et al. Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 2006; 90:1489-1500.
19. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97:425-434. (Pubitemid 46437805)
20. Ovanesov MV, Panteleev MA, Sinauridze EI, Kireev DA, Plyushch OP, Kopylov KG, et al. Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution. Blood Coagul Fibrinolysis 2008; 19:743-755.
21. Parunov LA, Fadeeva OA, Balandina AN, Soshitova NP, Kopylov KG, Kumskova MA, et al. Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost 2011; 9:1825-1834.
22. Hojima Y, Pierce JV, Pisano JJ. Hageman factor fragment inhibitor in corn seeds: purification and characterization. Thromb Res 1980; 20:149-162. (Pubitemid 11174769)
23. Sinauridze EI, Volkova RI, Krasotkina YV, Sarbash VI, Ataullakhanov FI. Dynamics of clot growth induced by thrombin diffusing into nonstirred citrate human plasma. Biochim Biophys Acta 1998; 1425:607-616. (Pubitemid 28546695)
24. Fadeeva OA, Panteleev MA, Karamzin SS, Balandina AN, Smirnov IV, Ataullakhanov FI. Thromboplastin immobilized on polystyrene surface exhibits kinetic characteristics close to those for the native protein and activates in vitro blood coagulation similarly to thromboplastin on fibroblasts. Biochemistry (Mosc) 2010; 75: 734-743.
25. Ataullakhanov FI, Volkova RI, Guriia GT, Sarbash VI. Spatial aspects of blood coagulation dynamics. III. Growth of clots in vitro. Biofizika 1995; 40:1320-1328.
26. Hoffman M, Monroe DM, Oliver JA, Roberts HR. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86:1794-1801.
27. Allen GA, Monroe DM III, Roberts HR, Hoffman M. The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation. Blood Coagul Fibrinolysis 2000; 11 (Suppl 1):S3-S7. (Pubitemid 30368694)
28. Campbell RA, Overmyer KA, Bagnell CR, Wolberg AS. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol 2008; 28:2247-2254.
29. Faxalv L, Tengvall P, Lindahl TL. Imaging of blood plasma coagulation and its propagation at surfaces. J Biomed Mater Res A 2008; 85:1129-1134. (Pubitemid 351717983)
30. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005; 33:341-348. (Pubitemid 40216547)
31. Schouten M, Wiersinga WJ, Levi M, van der PT. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83:536-545.
32. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96:1233-1239. (Pubitemid 40962100)
33. Oehmcke S, Herwald H. Contact system activation in severe infectious diseases. J Mol Med 2010; 88:121-126.
34. Ho CH. Can very high level of D-dimer exclusively predict the presence of thromboembolic diseases? J Chin Med Assoc 2011; 74:151-154.
35. Di NM, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007; 5:296-304. (Pubitemid 46139454)
36. Balandina AN, Shibeko AM, Kireev DA, Novikova AA, Shmirev II, Panteleev MA, Ataullakhanov FI. Positive feedback loops for factor V and factor VII activation supply sensitivity to local surface tissue factor density during blood coagulation. Biophys J 2011; 101:1816-1824.